Laddar...
Calcitonin gene-related peptide (receptor) antibodies: an exciting avenue for migraine treatment
Editorial summary Specific prophylactic migraine treatments are urgently needed because of the unmet needs of many migraine patients. Antibodies targeting calcitonin gene-related peptide (CGRP) or its receptor have recently shown efficacy in episodic and chronic migraine and will be available soon.
Sparad:
| Huvudupphovsmän: | , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
BMC
2018-02-01
|
| Serie: | Genome Medicine |
| Länkar: | http://link.springer.com/article/10.1186/s13073-018-0524-7 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|